Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000627081 | SCV000835067 | likely benign | Familial cold autoinflammatory syndrome 2 | 2023-12-22 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000627081 | SCV001158137 | uncertain significance | Familial cold autoinflammatory syndrome 2 | 2019-09-27 | criteria provided, single submitter | clinical testing | The NLRP12 c.1054C>T; p.Arg352Cys variant (rs199881207) is published in the medical literature in 3 unrelated individuals with periodic fever or autoimmune disease without urticaria (Jeru 2011, Rusmini 2016). The variant is reported in the ClinVar database (Variation ID: 523654) and in the general population with an allele frequency of 0.04% (102/282638 alleles) in the Genome Aggregation Database. The arginine at this position is moderately conserved and computational algorithms (PolyPhen-2, SIFT) predict this variant is deleterious. Experiments in cell culture show this variant did not affect the NF-KB inhibitory activity, but did enhance processing of caspase-1 compared to wild type (Jeru 2011); these authors suggested that this variant may act in a gain of function mechanism, in contrast to NLRP12 nonsense variants that appear to have a loss of function. However, given the limited clinical and functional data, the significance of the variant is uncertain at this time. References: Jeru I et al. Identification and functional consequences of a recurrent NLRP12 missense mutation in periodic fever syndromes. Arthritis Rheum. 2011 May;63(5):1459-64. Rusmini M et al. Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases. Ann Rheum Dis. 2016 Aug;75(8):1550-7. |
Ce |
RCV001311905 | SCV001502271 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | NLRP12: BP4 |
Genome Diagnostics Laboratory, |
RCV002263840 | SCV002542434 | likely benign | Autoinflammatory syndrome | 2020-02-01 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV000627081 | SCV002759339 | uncertain significance | Familial cold autoinflammatory syndrome 2 | 2022-12-07 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000627081 | SCV004805612 | likely benign | Familial cold autoinflammatory syndrome 2 | 2024-03-25 | criteria provided, single submitter | research | |
OMIM | RCV000627081 | SCV000747891 | pathogenic | Familial cold autoinflammatory syndrome 2 | 2023-04-18 | no assertion criteria provided | literature only | |
Diagnostic Laboratory, |
RCV001311905 | SCV001740400 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001311905 | SCV001965612 | uncertain significance | not provided | no assertion criteria provided | clinical testing |